Article | January 22, 2014

Financial Disclosure: CFR Part 54 vs. The Sunshine Act

By Nicole Mooney

The financial disclosure collection requirements under 21 CFR Part 54 have long been a major aspect of the initiation and study conduct of covered clinical studies. However, the newly released Physician Payments Sunshine Act aka “Sunshine Act” and “Open Payments” has shed some light on areas that were not always considered. Looking closely into these regulations, I found similarities between the two as well as some major differences.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma